ArticleTechnology in cancer research & treatment

Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2- Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population.

Yusi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.